1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3.
Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7.
Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customer
4.1.
Brand Awareness
4.2.
Preferred Mode of Purchase
4.3.
Major Factors Contributing to Mental Illness
4.4.
Willingness towards Psychobiotics Consumption
4.5.
Commonly Observed Psychological Effect Post Consumption
5. Clinical Trial Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical
Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Application
5.7. Breakdown of
Pipeline, By Region
5.8.
Clinical Trials Heat Map
6. Patents Analysis
7. Global Psychobiotics
Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value & Volume
7.2.
Market Share & Forecast
7.2.1.
By Psychotropic Agent (Streptococcus, Bifidobacterium,
Lactobacillus, Clostridium, Others)
7.2.2.
By Form (Powder, Liquid/Fluid, Tablets, Others)
7.2.3.
By Application (Stress Management, Mood Health & Mood
Upliftment, Depression, Anxiety, Sleep Problems, Others)
7.2.4. By
Region
7.2.5.
By Company (2022)
7.3.
Product Market Map
7.3.1.
By Psychotropic Agent
7.3.2.
By Form
7.3.3.
By Application
7.3.4.
By Region
7.4.
Pricing Analysis
8. North America
Psychobiotics Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value & Volume
8.2.
Market Share & Forecast
8.2.1.
By Psychotropic Agent (Streptococcus, Bifidobacterium,
Lactobacillus, Clostridium, Others)
8.2.2.
By Form (Powder, Liquid/Fluid, Tablets, Others)
8.2.3.
By Application (Stress Management, Mood Health & Mood
Upliftment, Depression, Anxiety, Sleep Problems, Others)
8.2.4.
By Country
8.3.
Pricing Analysis
8.4.
North America: Country Analysis
8.4.1.
United States Psychobiotics Market Outlook
8.4.1.1.
Market Size & Forecast
8.4.1.1.1.
By Value & Volume
8.4.1.2.
Market Share & Forecast
8.4.1.2.1.
By Psychotropic Agent
8.4.1.2.2.
By Form
8.4.1.2.3.
By Application
8.4.1.3.
Pricing Analysis
8.4.2.
Mexico Psychobiotics Market Outlook
8.4.2.1.
Market Size & Forecast
8.4.2.1.1.
By Value & Volume
8.4.2.2.
Market Share & Forecast
8.4.2.2.1.
By Psychotropic Agent
8.4.2.2.2.
By Form
8.4.2.2.3.
By Application
8.4.2.3.
Pricing Analysis
8.4.3.
Canada Psychobiotics Market Outlook
8.4.3.1.
Market Size & Forecast
8.4.3.1.1.
By Value & Volume
8.4.3.2.
Market Share & Forecast
8.4.3.2.1.
By Psychotropic Agent
8.4.3.2.2.
By Form
8.4.3.2.3.
By Application
8.4.3.3.
Pricing Analysis
9. Europe Psychobiotics
Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value & Volume
9.2.
Market Share & Forecast
9.2.1.
By Psychotropic Agent (Streptococcus, Bifidobacterium,
Lactobacillus, Clostridium, Others)
9.2.2.
By Form (Powder, Liquid/Fluid, Tablets, Others)
9.2.3.
By Application (Stress Management, Mood Health & Mood
Upliftment, Depression, Anxiety, Sleep Problems, Others)
9.2.4.
By Country
9.3.
Pricing Analysis
9.4.
Europe: Country Analysis
9.4.1.
France Psychobiotics Market Outlook
9.4.1.1.
Market Size & Forecast
9.4.1.1.1.
By Value & Volume
9.4.1.2.
Market Share & Forecast
9.4.1.2.1.
By Psychotropic Agent
9.4.1.2.2.
By Form
9.4.1.2.3.
By Application
9.4.1.3.
Pricing Analysis
9.4.2.
Germany Psychobiotics Market Outlook
9.4.2.1.
Market Size & Forecast
9.4.2.1.1.
By Value & Volume
9.4.2.2.
Market Share & Forecast
9.4.2.2.1.
By Psychotropic Agent
9.4.2.2.2.
By Form
9.4.2.2.3.
By Application
9.4.2.3.
Pricing Analysis
9.4.3.
United Kingdom Psychobiotics Market Outlook
9.4.3.1.
Market Size & Forecast
9.4.3.1.1.
By Value & Volume
9.4.3.2.
Market Share & Forecast
9.4.3.2.1.
By Psychotropic Agent
9.4.3.2.2.
By Form
9.4.3.2.3.
By Application
9.4.3.3.
Pricing Analysis
9.4.4.
Italy Psychobiotics Market Outlook
9.4.4.1.
Market Size & Forecast
9.4.4.1.1.
By Value & Volume
9.4.4.2.
Market Share & Forecast
9.4.4.2.1.
By Psychotropic Agent
9.4.4.2.2.
By Form
9.4.4.2.3.
By Application
9.4.4.3.
Pricing Analysis
9.4.5.
Spain Psychobiotics Market Outlook
9.4.5.1.
Market Size & Forecast
9.4.5.1.1.
By Value & Volume
9.4.5.2.
Market Share & Forecast
9.4.5.2.1.
By Psychotropic Agent
9.4.5.2.2.
By Form
9.4.5.2.3.
By Application
9.4.5.3.
Pricing Analysis
9.4.6.
Sweden Psychobiotics Market Outlook
9.4.6.1.
Market Size & Forecast
9.4.6.1.1.
By Value & Volume
9.4.6.2.
Market Share & Forecast
9.4.6.2.1.
By Psychotropic Agent
9.4.6.2.2.
By Form
9.4.6.2.3.
By Application
9.4.6.3.
Pricing Analysis
9.4.7.
Poland Psychobiotics Market Outlook
9.4.7.1.
Market Size & Forecast
9.4.7.1.1.
By Value & Volume
9.4.7.2.
Market Share & Forecast
9.4.7.2.1.
By Psychotropic Agent
9.4.7.2.2.
By Form
9.4.7.2.3.
By Application
9.4.7.3.
Pricing Analysis
9.4.8.
Slovakia Psychobiotics Market Outlook
9.4.8.1.
Market Size & Forecast
9.4.8.1.1.
By Value & Volume
9.4.8.2.
Market Share & Forecast
9.4.8.2.1.
By Psychotropic Agent
9.4.8.2.2.
By Form
9.4.8.2.3.
By Application
9.4.8.3.
Pricing Analysis
10. Asia-Pacific Psychobiotics
Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value & Volume
10.2.
Market Share & Forecast
10.2.1.
By Psychotropic Agent (Streptococcus, Bifidobacterium,
Lactobacillus, Clostridium, Other